Researchers in the US have developed an app that uses a smartphone camera and artificial intelligence algorithms to assess images of patients' poo for signs of disorders like
metaMe Health has enlisted the aid of health tech company Indegene to launch its recently-approved prescription digital therapeutic (DTx) Regulora for irritable bowel syndrome in the US.
Mahana Therapeutics has raised second-round financing of $61 million that will be used to launch what it says will be the first prescription digital therapeutic (DTx) for
AstraZeneca has amended a collaboration agreement with Ironwood Pharmaceuticals, gaining sole responsibility for developing, manufacturing and marketing an irritable bowel syndrome drug in
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho